Table 1.
Variable | ||
---|---|---|
Demographic characteristics | ||
Gender, male, n (%) | 132 (66%) | |
Age, years, mean ± SD | 63 ± 11 | |
Temporal relationship, metachronous, n (%) | 107 (54%) | |
Colon to hepatic surgery, months, median (IQR) (n = 192) | 12 (5–23) | |
CEA, μg/l, median (IQR) (n = 159) | 8 (4–27) | |
Elevated CEA, n (%) | 124 (78%) | |
Perioperative characteristics | ||
Resection, major, n (%) | 120 (60%) | |
Blood loss of >300 ml, n (%) (n = 195) | 68 (35%) | |
Transfusion, n (%) (n = 189) | 29 (15%) | |
Pringle duration >15 min, n (%) (n = 145) | 112 (77%) | |
Operating time, min, median (IQR) (n = 190) | 198 (150–266) | |
No complications, n (%) | 123 (62%) | |
Clavien–Dindo grade, n (%) (n = 198) | ||
Grade I | 17 (9%) | |
Grade II | 42 (21%) | |
Grade IIIa | 5 (3%) | |
Grade IIIb | 3 (2%) | |
Grade IVa | 2 (1%) | |
Grade IVb | 1 (1%) | |
Grade V | 5 (3%) | |
Primary tumour characteristics | ||
Location: colon, n (%) | 141 (71%) | |
Location: rectum, n (%) | 58 (29%) | |
Primary differentiation, poor, n (%) (n = 181) | 27 (15%) | |
Lymph node status positive, n (%) (n = 192) | 121 (63%) | |
Liver metastases characteristics | ||
Margin, mm, median (IQR) (n = 197) | 3 (1–10) | |
Margin R1 (0 mm), n (%) | 38 (19%) | |
Margin <1 mm, n (%) | 22 (11%) | |
Margin 1–10 mm, n (%) | 94 (48%) | |
Margin >10 mm, n (%) | 43 (22%) | |
Number of metastases, median (IQR) (n = 196) | 2 (1–2) | |
Size of metastases, mm, median (IQR) (n = 195) | 35 (24–57) |
Numbers available for analysis vary as shown.
SD, standard deviation; IQR, interquartile range; CEA, carcinoembryonic antigen.